14nov(nov 14)7:00 am15(nov 15)1:00 pmLife Sciences IP Due DiligenceOmni Parker House Hosted by: American Conference Institute

Hosted by

American Conference Institute

Event Details

The Annual Summit on Life Sciences IP Due Diligence is a one-of-a-kind, interactive forum where top diligence experts will discuss best practices and strategies for executing a proper IP due diligence analysis, both for your own portfolio, and that of potential targets. STAT Plus readers are being given the unique opportunity to register for the event at 10% off with discount code: D10-657-657IX01

Attendees will benefit from in-depth sessions which will help them to:

• Identify criteria that impacts the overall value of the deal during the IP valuation process

• Conduct international legal risk assessments and find appropriate resources for IP due diligence examinations

• Find funding options to facilitate business expansion and accelerate growth

• Mitigate the inherent risks presented in life sciences IP due diligence investigations

• Negotiate and draft the relevant documents to ensure a detailed, robust, and accurate agreement

There will also be great opportunities to network and benchmark strategies with professionals from leading life sciences companies including Akeba Therapeutics, Alexion Pharmaceuticals, Celgene, Dana-Farber Cancer Institute, Novartis Institutes for BioMedical Research, and Stryker. STAT Plus readers, register at 10% with discount code: D10-657-657IX01


Nov. 14 to Nov. 15


Omni Parker House

60 School Street

Boston, MA 02108

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy